
1. eur j haematol. 2018 mar;100(3):294-303. doi: 10.1111/ejh.13013. epub 2018 jan
15.

cytochemical flow analysis intracellular g6pd aggregate analysis mosaic
g6pd expression.

kalnoky m(1), bancone g(2)(3), kahn m(1), chu cs(2), chowwiwat n(2), wilaisrisak 
p(2), pal s(1), larue n(1), leader b(1), nosten f(2)(3), domingo gj(1).

author information: 
(1)diagnostics program, path, seattle, wa, usa.
(2)shoklo malaria research unit, mahidol-oxford tropical medicine research unit, 
faculty tropical medicine, mahidol university, mae sot, thailand.
(3)centre tropical medicine global health, nuffield department of
medicine research building, university oxford, oxford, uk.

background: medicines exert oxidative pressure red blood cells (rbc) 
cause severe hemolysis patients glucose-6-phosphate dehydrogenase (g6pd) 
deficiency. due x-chromosome inactivation, females heterozygous g6pd 
1 allele encoding g6pd-deficient protein normal protein produce
2 rbc populations expressing exclusively 1 allele. g6pd mosaic not
captured routine g6pd tests.
methods: open-source software tool g6pd cytofluorometric data
interpretation described. tool interprets data terms % bright rbc,
or cells normal g6pd activity specimens collected 2 geographically
and ethnically distinct populations, african american cohort (usa) karen
and burman ethnic cohort (thailand) comprising 242 specimens including 89
heterozygous females.
results: tool allowed comparison data across 2 laboratories both
populations. hemizygous normal deficient males homozygous normal or
deficient females cluster narrow % bright cells mean values 96%, 6%
(males) 97%, 2% (females), respectively. heterozygous females show a
distribution 10-85% bright cells mean 50%. distributions are
associated severity g6pd mutation.
conclusions: consistent cytofluorometric g6pd analysis facilitates
interlaboratory comparison cellular g6pd profiles contributes to
understanding primaquine-associated hemolytic risk.

Â© 2017 authors. european journal haematology published john wiley &
sons ltd.

doi: 10.1111/ejh.13013 
pmcid: pmc5888147
pmid: 29240263  [indexed medline]

